Jingjuan Ren, Ni Wang, He Zhu, Wenjuan Nie, Feng Sun, Yu Xiong, Liang Fu, Hui Luo, Shiming Cheng, Yanlin Zhao, Fei Huang. Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024J. China CDC Weekly, 2026, 8(21): 653-658. DOI: 10.46234/ccdcw2026.106
|
Citation:
|
Jingjuan Ren, Ni Wang, He Zhu, Wenjuan Nie, Feng Sun, Yu Xiong, Liang Fu, Hui Luo, Shiming Cheng, Yanlin Zhao, Fei Huang. Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024J. China CDC Weekly, 2026, 8(21): 653-658. DOI: 10.46234/ccdcw2026.106
|
Jingjuan Ren, Ni Wang, He Zhu, Wenjuan Nie, Feng Sun, Yu Xiong, Liang Fu, Hui Luo, Shiming Cheng, Yanlin Zhao, Fei Huang. Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024J. China CDC Weekly, 2026, 8(21): 653-658. DOI: 10.46234/ccdcw2026.106
|
Citation:
|
Jingjuan Ren, Ni Wang, He Zhu, Wenjuan Nie, Feng Sun, Yu Xiong, Liang Fu, Hui Luo, Shiming Cheng, Yanlin Zhao, Fei Huang. Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024J. China CDC Weekly, 2026, 8(21): 653-658. DOI: 10.46234/ccdcw2026.106
|